Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
iptacopan
The First People's Hospital of Lianyungang
Thrombotic Microangiopathy
1 trial -
leuprorelin
The First People's Hospital of Lianyungang
Hematopoietic Stem Cell Transplantation
1 trial -
live combined Bifidobacteriun, Lactobacillus and Enterococcus capsules
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
low-dose stem cell gel group
The First People's Hospital of Lianyungang
Burn Injury
1 trial -
metoclopramide or mosapride
The First People's Hospital of Lianyungang
Severe Stroke
1 trial -
modified BEAM
The First People's Hospital of Lianyungang
Autologous Stem Cell Transplantation
1 trial -
multi-vitamin carbohydrate
The First People's Hospital of Lianyungang
Nausea and Vomiting, Aspiration, Intraoperative
1 trial -
oxycodone and parecoxib sodium combinations
The First People's Hospital of Lianyungang
Oxycodone
1 trial -
parecoxib
The First People's Hospital of Lianyungang
Pain, Postoperative
1 trial -
parecoxib
The First People's Hospital of Lianyungang
Anti-Inflammatory Agents, Non-Steroidal
1 trial -
pre-packaged low-residue diet for bowel preparation
The First People's Hospital of Lianyungang
IBD (Inflammatory Bowel Disease)
1 trial -
pre-packaged low-residue diet for bowel preparation
The First People's Hospital of Lianyungang
Colonoscopy: Bowel Preparation
1 trial -
preoperative oral carbohydrate drink
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
probiotics
The First People's Hospital of Lianyungang
Ulcerative Colitis
1 trial -
propofol
The First People's Hospital of Lianyungang
Anesthesia
1 trial -
remimazolam combined with remifentanil
The First People's Hospital of Lianyungang
Difficult or Failed Intubation
1 trial -
routine aspirin and heparin treatment
The First People's Hospital of Lianyungang
Acupuncture
1 trial -
salbutamol
The First People's Hospital of Lianyungang
Liver Transplantation
1 trial -
simultaneous integrated boost intensity-modulated radiation therapy combined with ripretinib
The First People's Hospital of Lianyungang
Gastrointestinal Stromal Tumors
1 trial -
sodium bicarbonate Ringer's solution
The First People's Hospital of Lianyungang
Hepatic Ischemia
1 trial -
solu medrol
The First People's Hospital of Lianyungang
Immunosuppression
1 trial -
standard-of-care imaging (18F-FDG, 68Ga-PSMA, or 68Ga-DOTATATE PET/CT), 68Ga-MY6349 PET/CT
The First People's Hospital of Lianyungang
Tumor
1 trial -
tacrolimus
The First People's Hospital of Lianyungang
Renal Transplantation
1 trial -
telmisartan
The First People's Hospital of Lianyungang
Hypertension
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources